Latest filing published 17 May 2010 for OPTIMER PHARMACEUTICALS INC, €8,392.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Kevin P. Poulos: trading record in brief
Kevin P. Poulos is a declared insider of Optimer Pharmaceuticals Inc, with filings sourced from SEC (Form 4). Over a trading history stretching from 14 February 2007 to 17 May 2010, the count stands at 7 filings.
The open-market record is one-sided, with 4 purchases worth €18k and not one sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price.
In size, the median ticket on the buying side is €4,469.
On 17 May 2010 came the latest disclosure, a transaction for €8,392 in Optimer Pharmaceuticals Inc. The last purchase on record was published on 22 December 2008, which is 6,531 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Kevin P. Poulos
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,068 shares@ US$9.57Common stockSEC:0001142576-10-000027:0
- 1,009 shares@ US$9.91Common StockSEC:0001142576-09-000026:0
- 1,370 shares@ US$7.23Common stockSEC:0001142576-09-000021:0
- 1,243 shares@ US$6.18Common StockSEC:0001142576-08-000019:0Canonical exit: 15 Feb 2009 (T+90)
- 1,257 shares@ US$6.04Common StockSEC:0001142576-08-000014:0Canonical exit: 13 Aug 2008 (T+90)
- 600 shares@ US$7.00Common StockSEC:0001104659-07-011408:0Canonical exit: 15 May 2007 (T+90)
6 of 6 declarations
